



|
|
|
|
 |
Nicholas P. Xenopoulos, MD
Speciality: Cardiovascular Diseases
Medical School: Aristotelian University of Thessaloniki, Fac. of Medicine, Thessaloniki, Greece. Graduated 1985.
Residency: East Carolina University School of Medicine, Internal Medicine.
Fellowship: Wake Forest University Baptist Medical Center, Cardiovascular Diseases.
American Board of Medical Specialties Certification:
Internal Medicine
Cardiovascular Disease
Interventional Cardiology
Interests: Coronary and Peripheral Intervention, Intracoronary Ultrasound.
Publications: Severe right heart failure in a patient with Grave's disease. Clinical Cardiology. Nov. 1996.
WC Myocardial injury in electrocution. Am Heart J 122: 1481-2, 1991.
The effects of vasoactive intestinal peptide on myocardial performance. Am Journal Physiology (Heart Circ Physiol 35): H 399-H405, 1994.
The effects of vagal stimulation on myocardial performance. Am Journal Physiology (Heart Circ Physiol 35): H2167-73, 1994.
Transluminal extraction catheter atherectomy followed by immediate stenting in treating of saphenous vein grafts. Journal of Amer. Coll. Cardiology, Sept. 1997.
Research: Pride study: Protection during Saphenous Vein Graft Intervention to Prevent Distal Embolization.
Deliver study: Prospective, Randomized, Clinical Evaluation of the RX Achieve Drug Coated Coronary Stent System in the Treatment on Patients with De Novo Native Coronary Artery Lesions.
Protect-TIMI 30: A Randomized Trial to Evaluate the Relative Protection Against Post-PCI Microvascular Dysfunction and Post-PCI Ischemia Among Anti-Platelet and Anti-Thrombotic Agents.
Stellar Registry: Prospective Evaluation of the Impact of Stent Deployment Techniques on Clinical Outcomes of Patients Treated with the Cypher Stent. |
|
|
|
|
|
|
|
|